GeneScience Pharmaceuticals
GeneScience Pharmaceuticals Co., Ltd. is a biopharmaceutical company based in Changchun, China, specializing in the development and production of recombinant human growth hormone products. Established in 1996, the company’s product line includes Jintropin AQ, Jintropin for Injection for burn treatment, Genfulin for deep II-degree burns and wound healing, and Jintrotide, a synthetic octapeptide that regulates the secretion of growth hormone. These products cater to various medical fields, including burns, assisted reproduction, anti-aging, and oncology. GeneScience Pharmaceuticals operates a manufacturing facility that spans over 20,000 square meters, with a dedicated production area of 11,000 square meters. The company distributes its products through a network of distributors in multiple countries, including China, Colombia, Hong Kong, Russia, Ukraine, Uzbekistan, and Mexico.
1 past transactions
Rani Therapeutics
Venture Round in 2018
Rani Therapeutics, LLC is a clinical-stage biotherapeutics company focused on developing oral delivery systems for large drug molecules, including peptides, proteins, and antibodies. The company has created the RaniPill capsule, a novel and patented technology designed to replace traditional subcutaneous or intravenous injections with an oral dosing method. This capsule is engineered to automatically release a precise therapeutic dose of medication in the small intestine, aiming to enhance patient compliance and comfort. Rani Therapeutics has conducted several preclinical and clinical studies to assess the safety, tolerability, and bioavailability of the RaniPill, contributing to a robust intellectual property portfolio. The company's therapeutic offerings include treatments for inflammatory disorders, osteoporosis, growth deficiencies, and multiple sclerosis, among others. Founded in 2012 and based in San Jose, California, Rani Therapeutics seeks to improve patient outcomes by providing a convenient alternative to painful injections.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.